Upon reading a couple of sources, I found that the incidence of cardiac arrest in the United States is estimated to be around 356,000 cases a year, which is about 0.11% of the population. Some of the risk factors that are associated with cardiac arrest include coronary artery disease, previous heart attacks, Arrhythmias, high blood pressure, diabetes, smoking, obesity, physical inactivity, and a family history of heart disease. Heart attacks are a very critical condition with a high fatality rate. According to some of the sources I listed below, approximately 90% of people who experience a heart attack outside of a hospital setting do not survive. Some factors that influence the survival rate of heart attack are the speed of emergency responses, the availability of Automated External Defibrillators (AEDs), and the immediate initiation of cardiopulmonary resuscitation (CPR).
Ischemia/reperfusion (I/R) is a condition where the blood supply to a tissue is temporarily reduced or interrupted (ischemia) and then restored (reperfusion). This process can lead to biochemical and physiological changes in the affected tissue, possibly resulting in further injury. So, when blood flow is restored to the ischemic tissue, many harmful things can happen; one is called Oxidative Stress,which is thereintroduction of oxygen that can lead to the production of ROS, which can damage cells. The inflammatory response is another thing that can happen, and it is when the restoration of blood flow triggers an inflammatory response, attracting immune cells that may exacerbate tissue damage. Also, something called Calcium Overload, which means reperfusion, can lead to an influx of calcium ions into cells, causing cellular dysfunction and death. To close, I/R injury is commonly associated with various medical conditions, like heart attacks, stroke, organ transplants, and Peripheral artery disease.
Mitochondrial transplantation (MTx) is an exciting area of research, especially when it comes to its impact on neural cell health and survival after cardiac arrest (CA). A recent study by Hayashida et al. caught my attention, as it gathered some pretty compelling evidence about how donor mitochondria can be successfully transplanted into neural cells. What’s interesting is that these donor mitochondria actually team up with the cells’ own mitochondria and seem to work well together. The transplanted mitochondria weren’t just hanging out; they were actively engaged in respiration and producing ATP, which is crucial for cell energy.
In terms of actual results, the study showed a remarkable jump in survival rates. In rats that were given fresh mitochondria right after being resuscitated from cardiac arrest, survival rates soared from 55% to an impressive 91%! This stark increase really highlights how much of a difference mitochondrial transplantation can make in survival outcomes.
Another notable point from the study was the presence of these transplanted mitochondria in various vital organs like the brain, kidney, and spleen, 24 hours after the cardiac arrest. Unfortunately, researchers found that they didn’t stick around in the heart, liver, or lungs during that same time frame. This observation opens up several questions about how and why the mitochondria are able to persist in certain organs and whether they maintain their functionality past the first day. Do they start to break down? That’s definitely a line of inquiry worth exploring.
When it comes to comparing the effectiveness of fresh versus frozen mitochondria, the findings were pretty clear-cut. Freshly isolated mitochondria showed Real promise in providing protective effects and improving survival rates. In contrast, frozen-thawed mitochondria fell short; they didn’t seem to produce the same benefits. This leads us to think that the freezing process might compromise the functional integrity of mitochondria, which makes total sense when you consider how crucial it is for them to be viable and actively producing energy for therapy to work.
It’s fascinating to think about how much we still have to learn in this field. The study does suggest that fresh mitochondria are not just optional but essential for successful transplantation. If we truly want to harness the potential of mitochondrial therapy, we need to prioritize using fresh mitochondria for any clinical applications.
In the bigger picture, mitochondrial transplantation is shaping up to be a pretty viable therapeutic strategy. It has the potential not only to boost survival rates but also to enhance neurological functions after a cardiac arrest. The study also looked into other health indicators, such as blood lactate levels, lung edema (swelling due to fluid), glucose levels, and cerebral blood flow—all of which showed signs of improvement after mitochondrial transplantation.
The fact that these transplanted mitochondria can stick around in the tissues for at least 24 hours shows their potential role in recovery. It gives us hope that MTx could be a game-changer for patients recovering from serious health events like cardiac arrest. But again, the emphasis on using fresh mitochondria cannot be overstated. The frozen variety just doesn’t seem to cut it when it comes to offering the same level of protective effects.
All in all, while there’s still a lot more research to do in this area, the findings give us encouraging initial insights. As scientists dig deeper into optimizing mitochondrial transplantation protocols, we could be on the brink of something truly transformative for clinical applications. It’s exciting to see how this research could evolve and eventually benefit people who are facing life-threatening conditions. There’s a lot at stake, and understanding how best to utilize these tiny but mighty cellular powerhouses could lead to significant advancements in medicine.
References
Takeda, K., & Shimizu, S. (2018). “Ischemia-reperfusion injury: Mechanisms and therapeutic
strategies.” Nature Reviews Cardiology, 15(9), 609-624.
Yellon, D. M., & Baxter, G. F. (2000). “Reperfusion injury: A review.” Circulation Research,
87(3), 198-205.
Huang, H., & Zhang, J. (2020). “Mechanisms and therapeutic strategies for ischemia-
reperfusion injury in the heart.” Journal of Cardiovascular Pharmacology and Therapeutics, 25(1), 5-17.
American Heart Association. (2021). Heart Disease and Stroke Statistics—2021 Update. Circulation.
Benjamin, E. J., et al. (2019). Heart Disease and Stroke Statistics—2019 Update: A report from
the American Heart Association. Circulation.
McNally, B., et al. (2011). Out-of-Hospital Cardiac Arrest Surveillance—Cardiac Arrest
Registry to Enhance Survival (CARES), 2005-2010. Morbidity and Mortality Weekly Report.
Authors (Publication_Date). YouTube. Publication_Title, https://www.youtube.com/watch?v=pc7MyUs_ORQ
Murao A., Nishikimi M., Becker L. B., Yin T., Endo Y., Choudhary R. C., Miyara S. J., USA L., USA C., Nakamura E., Kuschner C., Wang P., Shinozaki K., Aoki T., Hayashida K., Kim J., Takegawa R., & Shoaib M. (2023, March 16). Exogenous mitochondrial transplantation improves survival and neurological outcomes after resuscitation from cardiac arrest – BMC Medicine. BioMed Central, https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02759-0
(2022, September 25). Tom Benson – Mitochondrial Transplantation Solves Mitochondrial Aging – EARD 2022. YouTube, https://www.youtube.com/watch?v=cvDI7ey1YuU
Gandy J., Perez-Costas E., Melendez-Ferro M., Bijur G., Roberts R., Barksdale K., & USA D. (Publication_Date). Mitochondrial viability in mouse and human postmortem brain – PMC. Publication_Title, https://pmc.ncbi.nlm.nih.gov/articles/PMC2923351/
USA D., USA D., Darley‐Usmar V., Karamanlidis G., Liesa M., Lagarrigue S., Switzerland D., Petcherski A., Amati F., Benavides G., Acin‐Perez R., USA D., Veliova M., USA D., USA M., Tian R., Benador I., USA M., USA M., USA C., Caudal A., Murphy A., Wanagat J., USA N., Vergnes L., Reue K., Shirihai O., Sacks H., Stiles L., USA D., USA D., & Divakaruni A. (Publication_Date). A novel approach to measure mitochondrial respiration in frozen biological samples – PMC. Publication_Title, https://pmc.ncbi.nlm.nih.gov/articles/PMC7327496/